prescription drug prices

Federal Health Policy Update for Thursday, September 9

The following is the latest health policy news from the federal government as of 2:30 p.m. on Thursday, September 9. Some of the language used below is taken directly from government documents. The White House The White House has issued a fact sheet outlining how the administration plans to improve the country’s readiness for future pandemics. The major elements of the plan are transforming medical defenses, ensuring situational awareness, strengthening public health systems, building core capabilities, and managing the mission. The White House has posted a transcript of the September 2 press briefing given by its COVID-19 response team and [...]

admin2021-09-09T17:42:36+00:00September 9, 2021|Center for Medicare and Medicaid Innovation, Centers for Medicare & Medicaid Services, CMMI, Congress, Coronavirus, COVID-19, MACPAC, Medicaid and CHIP Payment and Access Commission, Medicare post-acute care, Medicare regulations, Medicare reimbursement policy, MedPAC, post-acute care|

Lowering Prescription Drug Costs

Shifting Medicare Part B drug coverage into Medicare Part D. Reducing Medicare Part D co-pays for generic drugs. Increasing the number of pharmacy benefit managers. Establishing expedited review for new versions of brand-name drugs. Tying U.S. drug prices to prices paid for the same drugs in other countries. Using U.S. trade policies to compel other countries to pay more for American pharmaceutical products. These are among the ideas presented in a new report by the White House Council of Economic Advisers detailing steps that might be taken to reduce prescription drug prices in the U.S. To learn more about these [...]

admin2018-02-12T10:45:34+00:00February 12, 2018|Medicare|